ASI Pharma at IPHEX 2025, New Delhi

ASI Pharma at IPHEX 2025

Earlier this month, the ASI Pharma team travelled to New Delhi for IPHEX 2025, the 11th edition of India’s International Pharmaceutical & Healthcare Exhibition, held from 4–6 September at Bharat Mandapam, Pragati Maidan. Organised annually by Pharmexcil under India’s Ministry of Commerce, IPHEX brings together hundreds of Indian exporters with buyers, distributors and institutions from across the globe — and this year was no exception, with delegations from over 100 countries in attendance.

For a company built around global pharmaceutical sourcing and exports, IPHEX is one of the most important stops on our calendar. It’s where the relationships we maintain over calls and emails throughout the year finally happen face-to-face.

Meeting Our Partners

Over the three days of the exhibition, we had the opportunity to sit down with importers, distributors and institutional buyers from across Africa, CIS, MENA, Asia and Latin America — many of whom are long-standing partners, and some we were meeting for the very first time.

These conversations covered everything from product portfolios and regulatory documentation to new market opportunities and private-label possibilities — the kind of detailed discussion that’s hard to replicate outside an in-person meeting.

Client Moments

A few of the moments from the floor, meeting the people we’re proud to call our partners:

Discussing export requirements with a visiting delegation.

Reviewing product portfolios with distributors from our key markets.

A quick moment on the exhibition floor between meetings.

Looking Ahead

IPHEX 2025 was another reminder of why we do what we do — building long-term, trust-based partnerships that help bring quality, affordable pharmaceutical products to markets that need them. We’re grateful to everyone who stopped by our stall, and we’re already looking forward to continuing these conversations in the months ahead.

If you’d like to connect with the ASI Pharma team or learn more about our product portfolio, get in touch with us — we’d love to hear from you.